About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland) and was founded in 2006, with the mission to innovate ligand discovery and medicinal target identification.

Philochem has discovered innovative methodologies for biotechnology product development...>>

Recent News

Zürich (Switzerland),
3rd March, 2015

Philochem announces the publication in the prestigious journal Nature Chemistry of an article entitled 'Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation'.
(see full press release)

Upcoming Events

Boston (USA),
6th, November, 2015

Dario Neri, the co-founder and chairman of the scientific advisory board of Philogen will deliver the keynote speech at the First Boston Symposium of Encoded Library Platforms in Boston, 6th November. The title of his presentation will be 'Single-Pharmacophore and Dual-Pharmacophore DNA-Encoded Chemical Libraries: A Comparative Evaluation'.